Aradigm Corporation Names John Siebert To The Board Of Directors
07 Nov 2006
HAYWARD, CA -- (MARKET WIRE) -- November 06, 2006 -- The Board of Directors of Aradigm Corporation (NASDAQ: ARDM) today announced the appointment of John M. Siebert, Ph.D. to the Board of Directors. Dr. Siebert is currently the Chairman and CEO of CyDex, a privately-held company that has been successfully out-licensing its substituted cyclodextrin technology for use in drug development and formulation to a number of major pharmaceutical companies. CyDex also uses that technology to develop proprietary products which are out-licensed or may be brought to market by CyDex in the future.
Organizations
Indications
-Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.